AV
UTHR icon

ASR Vermogensbeheer’s United Therapeutics UTHR Stock Holding History

ASR Vermogensbeheer’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Buy
19,047
+17,826
+1,460% +$10M 0.11% 187
2026
Q1 		$724K Buy
1,221
+29
+2% +$14.4K 0.01% 457
2025
Q4 		$581K Sell
1,192
-15
-1% -$6.99K 0.01% 470
2025
Q3 		$506K Sell
1,207
-14
-1% -$4.71K 0.01% 483
2025
Q2 		$351K Sell
1,221
-6
-0.5% -$1.79K ﹤0.01% 520
2025
Q1 		$378K Buy
+1,227
New +$420K 0.01% 514

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

ASR Vermogensbeheer's UTHR Position: Q2 2026 in Review

ASR Vermogensbeheer increased its United Therapeutics (UTHR) stake by 1,460% in Q2 2026, buying an estimated $10M and bringing the position to 19,047 shares worth $10.3M. The position accounts for 0.11% of the portfolio, ranked #187.

ASR Vermogensbeheer first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • ASR Vermogensbeheer held 19,047 shares of United Therapeutics worth $10.3M as of Q2 2026.
  • ASR Vermogensbeheer bought 17,826 United Therapeutics shares in Q2 2026, an estimated $10M.
  • United Therapeutics made up 0.11% of ASR Vermogensbeheer's portfolio in Q2 2026, its #187 holding.
  • ASR Vermogensbeheer first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.